Press "Enter" to skip to content

New patent expiration for Otsuka drug ABILIFY

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Otsuka drug ABILIFY

Annual Drug Patent Expirations for ABILIFY
Annual Drug Patent Expirations for ABILIFY

Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from two suppliers. There are forty-nine patents protecting this drug and three Paragraph IV challenges.

ABILIFY drug price trends.

Drug patent litigation for ABILIFY.

This drug has two hundred and thirty-six patent family members in thirty-six countries.

The generic ingredient in ABILIFY is aripiprazole. Two suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Otsuka drug ABILIFY
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions